Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice

Alcoholism, Clinical and Experimental Research
Dennis R SpartaTodd E Thiele

Abstract

Neuropeptide Y (NPY) is a 36-amino acid neuromodulator that is expressed throughout the central nervous system. Recent genetic and pharmacological evidence suggests that the NPY Y1 receptor modulates ethanol intake. To further characterize the role of the Y1 receptor, we examined voluntary ethanol consumption by mice after administration of [(-)-2-[1-(3-chloro-5-isopropyloxycarbonylaminophenyl)ethylamino]-6-[2-(5-ethyl-4-methyl-1,3-tiazol-2-yl)ethyl]-4-morpholinopyridine] (compound A), a novel and selective Y1 receptor antagonist (Y1RA) that acts centrally on brain receptors when administered peripherally. C57BL/6J mice were habituated to drinking a 10% (v/v) ethanol solution by using a two-bottle-choice procedure and were then given an intraperitoneal (ip) injection (5 ml/kg) of the Y1RA (0, 25, 50, or 75 mg/kg). In a second study, mice were given intracerebroventricular infusion of the Y1RA (0, 30, or 100 microg). Finally, we determined whether the Y1RA alters open-field locomotor activity, ethanol-induced sedation (3.8 g/kg, ip), or blood ethanol levels. Relative to control treatment, ip injection (50 and 75 mg/kg) and intracerebroventricular infusion (100 microg) of the Y1RA significantly reduced ethanol consumption and foo...Continue Reading

References

Jan 1, 1992·Progress in Neurobiology·Y DumontR Quirion
Nov 1, 1984·Peptides·A S Levine, J E Morley
Jun 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M HeiligK T Britton
May 17, 1996·Neuroreport·D A GolombekM E Harrington
Oct 21, 1996·Brain Research·D P WoldbyeT G Bolwig
Jun 1, 1997·Alcoholism, Clinical and Experimental Research·C MöllerM Heilig
Jul 11, 1998·Alcoholism, Clinical and Experimental Research·L G CarrT K Li
Jan 9, 1999·Mammalian Genome : Official Journal of the International Mammalian Genome Society·P BiceL G Carr
Jul 3, 1999·Progress in Neuro-psychopharmacology & Biological Psychiatry·A KaskJ Harro
Dec 3, 1999·Biochemical and Biophysical Research Communications·A KanataniM Ihara
Jul 11, 2000·Alcoholism, Clinical and Experimental Research·T E ThieleI L Bernstein
Jul 19, 2000·Pharmacology, Biochemistry, and Behavior·C J SlaweckiC L Ehlers
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·T E ThieleR D Palmiter
Apr 6, 2001·Alcoholism, Clinical and Experimental Research·N E Badia-ElderT K Li
Apr 20, 2001·Nature·D E HanselG V Ronnett
Jul 17, 2001·The European Journal of Neuroscience·P NaveilhanP Ernfors
Oct 13, 2001·Journal of Neuroscience Research·D E HanselG V Ronnett
Jul 11, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·David P D WoldbyeTom G Bolwig
Feb 27, 2003·Alcoholism, Clinical and Experimental Research·Subhash C PandeyTodd E Thiele
Mar 11, 2003·Experimental Biology and Medicine·Magnus M BerglundDonald R Gehlert
May 27, 2003·Alcoholism, Clinical and Experimental Research·Nicholas W GilpinNancy E Badia-Elder
Jun 24, 2003·Physiology & Behavior·Todd E Thiele, Nancy E Badia-Elder

❮ Previous
Next ❯

Citations

Apr 14, 2006·Current Opinion in Psychiatry·Susumu HiguchiHaruo Kashima
Jun 7, 2005·Expert Opinion on Emerging Drugs·Raye Z LittenMark Egli
Jan 19, 2016·Behavioural Brain Research·Amanda M Barkley-LevensonJohn C Crabbe
May 8, 2007·Pharmacology, Biochemistry, and Behavior·Clifford M KnappConan Kornetsky
May 7, 2011·British Journal of Pharmacology·Ernie YulyaningsihAmanda Sainsbury
Sep 23, 2006·Frontiers in Neuroendocrinology·Carola EvaAlessandra Oberto
Nov 30, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ravi K Sajja, Shafiqur Rahman
Nov 22, 2011·Neuroscience and Biobehavioral Reviews·Nicholas W Gilpin, Marisa Roberto
Jul 11, 2008·Neuron·George F Koob
Sep 4, 2007·Biochemical Pharmacology·Aviel Goodman
Apr 23, 2017·Neuropharmacology·Howard C Becker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.